Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Lartesertib

Cat. No.: OB0225WX-2352
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
Lartesertib
Add to basket

Product Overview

Description: Lartesertib is a small-molecule inhibitor of the serine/threonine protein kinase ATM.
Synonym: ATM Inhibitor-5; M4076; 2495096-26-7; M-4076; (Rac)-Lartesertib; 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-2H-imidazo(4,5-C)quinolin-2-one; 2H-Imidazo(4,5-C)quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-; 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoranyl-5-methoxy-pyridin-4-yl)-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one; 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methylimidazo[4,5-c]quinolin-2-one; 2H-Imidazo[4,5-c]quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-; 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methylimidazo(4,5-c)quinolin-2-one; 8-(1,3-Dimethylpyrazol-4- yl)-1-[3-fluoro-5-(trideuterio- methoxy)-4-pyridyl]-7- methoxy-3-methyl-imidazo- [4,5-c]quinolin-2-one; 2H-Imidazo[4,5-c]quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-, (1S)-; 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5- methoxypyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydro- 2H-imidazo[4,5-c]quinolin-2-one; 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydro2H-imidazo[4,5-c]quinolin-2-one; 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(Sa)-(3-fluoro-5-methoxy-pyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one
CAS No.: 2495096-26-7
Compound CID: 122599280
Formula: C23H21FN6O3
Formula Weight: 448.45

Specification

Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Lartesertib is applied in molecular pharmacology to study the selective inhibition of DNA-PK and its role in modulating DNA double-strand break repair and sensitizing cancer cells to radiotherapy.

Library Information

Target: ATM/ATR
Receptor: ATM
Pathways: DNA damage/DNA repair; PI3K/Akt/mTOR signaling
Plate Number: AOCL-31
Plate Location: b4
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 80 mg/mL; 178.39 mM
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.